Back to Results
First PageMeta Content
Technology / Clinical research / Pharmaceuticals policy / Botulinum toxin / Plastic surgery / Environmental Working Group / Validation / Regulatory requirement / Clostridium botulinum / Medicine / Neurotoxins / Biology


ZEBET’s Activities to Promote Alternative Methods to the LD50 Potency Test in Botulinum Neurotoxin Product Testing FEDERAL INSTITUTE FOR RISK ASSESSMENT
Add to Reading List

Document Date: 2015-05-25 17:30:22


Open Document

File Size: 213,04 KB

Share Result on Facebook

City

Berlin / Hannover / /

Company

Merz Pharmaceuticals / Allergan Inc. (USA) / BfArM / BoNT Expert Working Group / Ipsen Biopharm Limited / Stephens / /

Continent

Europe / /

Country

United States / United Kingdom / /

/

Event

Business Partnership / /

Facility

Federal Institute / Paul Ehrlich Institute / Free University / Botulinum Neurotoxin Product Testing FEDERAL INSTITUTE FOR RISK ASSESSMENT Federal Institute / National Institute / German Federal Institute / /

/

IndustryTerm

final reconstituted product / final product / manufacturing process / /

Organization

EWG / Food and Drug Administration / Free University Berlin / Center for Alternative Methods / National Institute for Biological Standards and Control / Federal Institute for Drugs and Medical Devices / European Commission / FDA / Medicines Board / Home Office / Federal Ministry of Education / Botulinum Neurotoxin Product Testing FEDERAL INSTITUTE FOR RISK ASSESSMENT Federal Institute for Risk Assessment / French Health Products Safety Agency / European Union / German Federal Institute for Risk Assessment / European Directorate for the Quality of Medicines / Paul Ehrlich Institute / Joint Research Centre / /

Person

Barbara Grune / Manfred Liebsch Medicinal / Andreas Luch / Sarah Adler / /

/

Position

Bishop / chair / /

PublishedMedium

the BoNT EWG Drying Review / /

URL

http /

SocialTag